Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan T Hennessy

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
BMC Medical Genomics|July 5, 2020
Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expressionDamien Kaukonen, Riina Kaukonen, Lélia Polit, et al.
Nature Reviews. Drug Discovery|December 13, 2005
Exploiting the PI3K/AKT pathway for cancer drug discoveryBryan T Hennessy, Debra L Smith, Prahlad T Ram, et al.
The Oncologist|July 25, 2012
Management of unusual histological types of breast cancerKaren A Cadoo, Orla McArdle, Anne-Marie O'Shea, et al.
Journal of Pathology and Translational Medicine|September 24, 2021
Fusobacterium nucleatum: caution with interpreting historical patient sample cohortKate L F Johnstone, Sinead Toomey, Stephen Madden, et al.
BMC Cancer|February 11, 2018
Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitroOzlem Aslan, Mattia Cremona, Clare Morgan, et al.
Frontiers in Oncology|February 12, 2025
Case report: Clonal evolution analysis of a rare case of meningioma lung metastases identifies actionable alterations in matched longitudinal tumour samplesNicola Cosgrove, Orla M Fitzpatrick, Liam Grogan, et al.
Journal of Pharmaceutical Sciences|April 5, 2014
PARP Inhibitors as P-glyoprotein SubstratesDenise Lawlor, Patricia Martin, Steven Busschots, et al.
Breathe (Sheffield, England)|August 21, 2025
Liquid biopsy in lung cancerSile Toland, Padraic Ridge, Emmet O'Brien, et al.
Frontiers in Oncology|February 16, 2023
Review of the status of neoadjuvant therapy in HER2-positive breast cancerGavin P Dowling, Stephen Keelan, Sinead Toomey, et al.
Cancer Research|June 4, 2009
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progressionRachelle L Dillon, Richard Marcotte, Bryan T Hennessy, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
BMC Medical Genomics|July 5, 2020
Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expressionDamien Kaukonen, Riina Kaukonen, Lélia Polit, et al.
Nature Reviews. Drug Discovery|December 13, 2005
Exploiting the PI3K/AKT pathway for cancer drug discoveryBryan T Hennessy, Debra L Smith, Prahlad T Ram, et al.
The Oncologist|July 25, 2012
Management of unusual histological types of breast cancerKaren A Cadoo, Orla McArdle, Anne-Marie O'Shea, et al.
Journal of Pathology and Translational Medicine|September 24, 2021
Fusobacterium nucleatum: caution with interpreting historical patient sample cohortKate L F Johnstone, Sinead Toomey, Stephen Madden, et al.
BMC Cancer|February 11, 2018
Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitroOzlem Aslan, Mattia Cremona, Clare Morgan, et al.
Frontiers in Oncology|February 12, 2025
Case report: Clonal evolution analysis of a rare case of meningioma lung metastases identifies actionable alterations in matched longitudinal tumour samplesNicola Cosgrove, Orla M Fitzpatrick, Liam Grogan, et al.
Journal of Pharmaceutical Sciences|April 5, 2014
PARP Inhibitors as P-glyoprotein SubstratesDenise Lawlor, Patricia Martin, Steven Busschots, et al.
Breathe (Sheffield, England)|August 21, 2025
Liquid biopsy in lung cancerSile Toland, Padraic Ridge, Emmet O'Brien, et al.
Frontiers in Oncology|February 16, 2023
Review of the status of neoadjuvant therapy in HER2-positive breast cancerGavin P Dowling, Stephen Keelan, Sinead Toomey, et al.
Cancer Research|June 4, 2009
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progressionRachelle L Dillon, Richard Marcotte, Bryan T Hennessy, et al.
Pageof 17